ArticleJournal of clinical and experimental hepatology
Splenic Artery Embolization in Living Donor Liver Transplant Recipients: Indications, Safety and Clinical Outcomes.
Article in Journal of clinical and experimental hepatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Multimodal clinical-imaging deep learning model for predicting refractory hypersplenism after liver transplantation.Scientific reports · 2026Article
- Proximal Splenic Artery Embolization: A Promising and Potential Tool.Journal of clinical and experimental hepatologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Splenic artery embolization (SAE) is a minimally invasive interventional radiology (IR) procedure that plays an important role in the management of complications in a certain subgroup of liver transplant recipients. SAE is technically of two types - proximal (P-SAE) and distal (D-SAE). There is limited data regarding the role of SAE in liver transplant recipients. The purpose of this study was to describe the role and outcomes of SAE in LDLT recipients based on the indications and the type of procedure used. Material and methods: Twenty-seven consecutive patients who underwent SAE after LDLT at our institute were retrospectively reviewed. Patients were categorized into two groups - those who underwent P-SAE (n = 7) and D-SAE (n = 20). The embolic agents used were coils or plugs in the P-SAE group; and poly vinyl alcohol (PVA) particles in the D-SAE group. Results: The median follow-up of the study population was 101 days. The mean platelet and lymphocyte counts improved markedly after SAE ( Conclusion: Our results support the use of P-SAE for the management of splenic artery steal and small-for-size graft syndromes; and D-SAE for the management of hypersplenism and refractory ascites. Both procedures are safe and effective and the decision to perform proximal or distal SAE should be based on the indications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.